Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q6FU45

Entry ID Method Resolution Chain Position Source
AF-Q6FU45-F1 Predicted AlphaFoldDB

No variants for Q6FU45

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q6FU45

No associated diseases with Q6FU45

1 regional properties for Q6FU45

Type Name Position InterPro Accession
domain Small GTP-binding protein domain 24 - 167 IPR005225

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
  • Cytoplasm
  • Nucleus and/or cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
mitochondrion A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
mRNA cleavage factor complex Any macromolecular complex involved in cleavage or polyadenylation of mRNA molecules.

1 GO annotations of molecular function

Name Definition
RNA binding Binding to an RNA molecule or a portion thereof.

3 GO annotations of biological process

Name Definition
mRNA polyadenylation The enzymatic addition of a sequence of 40-200 adenylyl residues at the 3' end of a eukaryotic mRNA primary transcript.
pre-mRNA cleavage required for polyadenylation The targeted, endonucleolytic cleavage of a pre-mRNA, required for polyadenylation of the 3' end. This cleavage is directed by binding sites near the 3' end of the mRNA and leaves a 3' hydoxyl end which then becomes a target for adenylation.
response to DNA damage checkpoint signaling A process that occurs in response to signals generated as a result of DNA damage checkpoint signaling.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MSTTNEETQA NASKDYSEDA LKMSYAAQPL DIMRALKLIE YYESKDDYDN SRKLYAELHE
70 80 90 100 110 120
RFPLYSPLWT MHLQSELQRN EFDTVEKLLA QCLAGDLENN DLSLWSTYLD YVRRKNNLIT
130 140 150 160 170 180
GGQEARAVVI KAFKLVMDKC ATFEPKASSF WNDYLGFLHQ WKPMNKWEEQ QRLDMIREVY
190 200 210 220 230 240
KKMLCVPFDK LEKMWNQYTL WEQETNTLTA RKFIGELSAD YMKARSIYQE LLNVTANIRR
250 260 270 280 290 300
TSPLNLRTAN KNNIPQYVLP CKKNDHTQLE AWLKWIAWEK ENKLELTEDA LKDRVTYVYK
310 320 330 340 350 360
QAIQQLLFEP EIWYDYVMYE FDNDAARKNI LKVALQANPT SPTLTFKLAE CYEVENKSEE
370 380 390 400 410 420
VQNCFEKTID ELLRQYKNDN GNDELSSDII WERKTLTYIY CIYMNTMKRL SGLSAARAVF
430 440 450 460 470 480
GKCRKLKKAM THDIYVENAY LEFQNQNDHK TASKVLELGL KYFGDDGEYI NKYMDFLSLL
490 500 510 520 530 540
NRGSQMKTLF ETSIEKVEDL RQLKKIYVKM IGYESKYGNL NNVYQLEKRF FEKFPDTDLI
550 560 570 580 590 600
QLFSTRYKIQ DDNKIKNLEL TYKLPDIISS DGDPSGVDKS FKKRQIENDE NLPDSKRQKS
610 620 630 640
QPLLPKEILD ILAVLPKKQY FKNAFLDPSN LVNYLNEQVK LADEEN